To all ADMINS here -
Drugs.com - I have just seen the following email alert from drugs.com re some Type 2 Prescriptions and thought I would pass it on.
Home › News › FDA Alerts › SGLT2...Print Share
SGLT2 Inhibitors: Drug Safety Communication - Labels to Include Warnings About Too Much Acid in the Blood and Serious Urinary Tract Infections
December 4, 2015
Audience: Pharmacy, Emergency Medicine
ISSUE: An FDA safety review has resulted in adding warnings to the labels of a specific class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors about the risks of too much acid in the blood and of serious urinary tract infections. Both conditions can result in hospitalization.